Axonics Inc is a pioneering medical technology firm focused on addressing bladder and bowel dysfunctions. It offers innovative sacral neuromodulation (SNM) systems designed to alleviate symptoms of overactive bladder, fecal incontinence, and urinary retention. These systems work by delivering mild electrical pulses to nerves, helping to restore normal bodily functions. Additionally, Axonics provides Bulkamid, a treatment for female stress urinary incontinence. With a global presence, the company markets its products directly and through distributors in various countries, headquartered in Irvine, California.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk and Zoom Video Communications.
